Call Us Now
 
Facebook-f Instagram Linkedin-in
CONTACT US
LOGIN

Dorzolamide Timolol Eye Drops in Delhi: A Specialized Ophthalmic Solution for Glaucoma Care

Dorzolamide Timolol Eye Drops for Delhi's Ophthalmic Market

Delhi has a broad healthcare ecosystem supported by hospitals, specialist eye-care clinics, pharmacies, distributors and pharmaceutical businesses. Within this environment, ophthalmic products from EyeKare Kilitch require appropriate formulations, controlled manufacturing and dependable supply. Anti-glaucoma medicines form an important specialized category, with different active ingredients and combinations used according to individual clinical requirements. 

EyeKare Kilitch is focused on ophthalmology and lists DORZOEYE-T as Dorzolamide & Timolol Preservative Free Eye Drops IP. The product contains Dorzolamide Hydrochloride equivalent to Dorzolamide 2.0% w/v and Timolol Maleate equivalent to Timolol 0.5% w/v. For organizations researching Dorzolamide Timolol Eye Drops in Delhi, this provides a clearly identified combination formulation within EyeKare’s anti-glaucoma portfolio.

Understanding the Dorzolamide and Timolol Combination

Dorzolamide and Timolol are two different active ingredients used in glaucoma management. Dorzolamide is a carbonic anhydrase inhibitor, while Timolol is a beta-blocker. A combination formulation brings both active ingredients into one ophthalmic product, which may be prescribed when a multi-mechanism approach is clinically appropriate. 

EyeKare’s DORZOEYE-T is specifically listed as a preservative-free eye drop. Its official product page provides the composition and identifies the formulation as Dorzolamide & Timolol Preservative Free Eye Drops IP. This information gives healthcare businesses a defined product profile to evaluate alongside approved product documentation and professional requirements.

DORZOEYE-T: EyeKare's Dorzolamide Timolol Formulation

DORZOEYE-T is part of EyeKare Kilitch’s anti-glaucoma portfolio. The formulation combines Dorzolamide Hydrochloride and Timolol Maleate at the strengths stated in the company’s product information. Its preservative-free positioning is a notable feature for businesses reviewing ophthalmic products for the glaucoma segment. 

A clearly specified formulation can help distributors, hospitals and pharmacy networks assess products more efficiently. Product strength, dosage form, packaging, approved indications and applicable regulatory documentation should all be reviewed when evaluating a pharmaceutical product for a particular healthcare channel.

Why Preservative-Free Ophthalmic Formulations Matter

Preservative-free delivery is an important area of EyeKare’s ophthalmic technology focus. The company describes its Novelia technology as a multi-dose closing-tip system designed to avoid preservatives while helping prevent bacterial contamination during the treatment period. EyeKare also highlights a 3K Triple Protection System for preservative-free medications and identifies glaucoma among its applications. 

For organizations evaluating glaucoma products, preservative-free availability can be considered alongside the active ingredients, formulation, packaging system and approved product information. The suitability of a particular medicine depends on professional assessment and should not be determined solely from its preservative status. 

Manufacturing and Quality Considerations

Ophthalmic manufacturing requires controlled production because products are intended for application to the eye. EyeKare states that its products are manufactured in-house at a facility spread across 3,50,000 square feet and describes the facility as compliant with international standards. The company also highlights more than 50 scientists working across research and development and quality control.

When selecting an ophthalmic manufacturing partner, businesses can review manufacturing infrastructure, formulation capabilities, quality-control systems, product documentation, packaging technology and supply reliability. These factors are particularly relevant for specialized anti-glaucoma products where consistent production and appropriate delivery are important considerations. 

Dorzolamide Timolol in Glaucoma Care

Glaucoma includes a group of eye conditions that can damage the optic nerve, and treatment varies according to the patient’s condition and clinical assessment. Ophthalmologists may use different medicines or combinations to manage intraocular pressure and other treatment objectives. 

DORZOEYE-T gives EyeKare’s portfolio a combination option containing Dorzolamide and Timolol. It sits alongside other anti-glaucoma products listed by EyeKare, including DORZOEYE, TIMOEYE, Travoprost formulations, Brinzolamide and Brimonidine combinations, and Brimonidine with Timolol. This range allows businesses to evaluate multiple ophthalmic options through a specialized portfolio.

What to Consider When Selecting Dorzolamide Timolol Eye Drops

Confirm the Composition 

The active ingredients and strengths should be checked against the approved product information. EyeKare lists DORZOEYE-T with Dorzolamide equivalent to 2.0% w/v and Timolol equivalent to 0.5% w/v. Confirming these details helps procurement teams evaluate the exact formulation required. 

Review Preservative-Free Availability 

DORZOEYE-T is listed as a preservative-free eye drop. Businesses evaluating the product should consider this characteristic together with packaging, storage, handling and other requirements provided in the relevant product documentation. 

Evaluate the Manufacturer 

A specialist ophthalmic manufacturer should be assessed through its production capabilities, quality systems, documentation, product range and supply support. This broader review can help businesses select a partner rather than evaluating a product on one characteristic alone. 

EyeKare's Ophthalmology-Focused Product Portfolio

EyeKare Kilitch describes itself as the specialized ophthalmic division of Kilitch Healthcare India Ltd. Its portfolio covers anti-glaucoma products along with lubricants, anti-allergic formulations, antibiotics, NSAIDs and other eye-care categories. This specialized focus can be relevant for distributors and healthcare businesses seeking an ophthalmology-oriented supplier. 

Businesses can review the EyeKare ophthalmic product portfolio to compare DORZOEYE-T with other formulations. Reviewing the wider range can help procurement teams understand the available therapeutic categories and identify products aligned with their market and healthcare-channel requirements. 

Supporting Ophthalmic Procurement in Delhi

Delhi’s network of hospitals, eye-care specialists, pharmacies and pharmaceutical distributors creates demand for focused ophthalmic products. For businesses serving these channels, a defined anti-glaucoma portfolio can make product evaluation and procurement planning more structured. 

EyeKare’s combination of ophthalmology specialization, in-house manufacturing and a broad ophthalmic product range gives organizations several factors to consider when assessing the company. Its DORZOEYE-T formulation provides a specific Dorzolamide and Timolol option for evaluation within the anti-glaucoma category. 

Why Consider EyeKare Kilitch for Dorzolamide Timolol?

EyeKare Kilitch offers DORZOEYE-T as a preservative-free Dorzolamide and Timolol eye-drop formulation, supported by a broader anti-glaucoma range. The company’s stated ophthalmology focus and in-house manufacturing approach provide additional areas for businesses to evaluate when selecting a specialized supplier. 

For organizations evaluating DORZOEYE-T Dorzolamide & Timolol eye drops, the composition, preservative-free positioning and manufacturing background can be considered together with product documentation and professional requirements. This provides a more complete basis for procurement decisions. 

Conclusion

Dorzolamide Timolol is a specialized combination within glaucoma care, and EyeKare Kilitch lists DORZOEYE-T as Dorzolamide & Timolol Preservative Free Eye Drops IP. Its stated composition includes Dorzolamide equivalent to 2.0% w/v and Timolol equivalent to 0.5% w/v.

For businesses searching for Dorzolamide Timolol Eye Drops in Delhi, EyeKare Kilitch offers a clearly identified combination formulation within its ophthalmology-focused portfolio. Product selection should be based on approved product information, professional guidance, regulatory requirements and the specific needs of the intended healthcare channel. 

Subscribe Our News Letter!

Subscribe to the EyeCare newsletter to receive updates on the latest developments, events and innovations in ophthalmology.

EyeKare Kilitch  is an innovative pharmaceutical company that discovers, develop, manufactures and market a broad range of healthcare products.

Facebook-f Instagram

Useful links

Contact Us

+91-22-6137 2222

info@eyekare.in

902-B, Godrej Coliseum, Behind Everard Nagar, Off. Eastern Express Highway, Nr. Priyadarshani Circle, Sion (E.), Mumbai - 400 022. INDIA.

© Copyright 2024 – EyeKareKilitch

Group of Companies